| Literature DB >> 23457325 |
Akio Kikuchi1, Toru Baba, Takafumi Hasegawa, Michiko Kobayashi, Naoto Sugeno, Masatoshi Konno, Emiko Miura, Yoshiyuki Hosokai, Toshiyuki Ishioka, Yoshiyuki Nishio, Kazumi Hirayama, Kyoko Suzuki, Masashi Aoki, Shoki Takahashi, Hiroshi Fukuda, Yasuto Itoyama, Etsuro Mori, Atsushi Takeda.
Abstract
OBJECTIVE: Dysphagia is one of the cardinal symptoms of Parkinson's disease (PD). It is closely related to the quality of life and longevity of PD patients. The aim of the study is to clarify the pathophysiological mechanisms responsible for dysphagia in PD.Entities:
Year: 2013 PMID: 23457325 PMCID: PMC3612769 DOI: 10.1136/bmjopen-2012-002249
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Parkinson's disease patients and follow-up flow diagram.
Profiles of PD patients
| Baseline | Follow-up | |||
|---|---|---|---|---|
| Parameters | With dysphagia | Without dysphagia | With dysphagia | Without dysphagia |
| Number of patients | 8 | 15 | ||
| Sex (M/W) | 6/ 2 | 4 /11 | ||
| Age (years) | ||||
| Mean | 67.8±3.11 | 65.2±4.02 | ||
| Range | 63–71 | 60–74 | ||
| Disease duration (years) | 6.75±3.73* | 3.53±3.58 | ||
| MMSE | 28.5±1.93 | 28.5±1.51 | 27.9 ± 2.80 | 28.4 ± 1.60 |
| Hoehn-Yahr stage | 2.75±0.27 | 2.37±0.67 | 3.06 ± 0.42 | 2.93 ± 0.53 |
| UPDRS motor score | 23.4±7.05* | 14.8±7.49 | 21.0 ± 5.93 | 17.4 ± 11.1 |
| L-dopa equivalent dose (mg/day) | 400±311 | 267±321 | 590±155 | 514±311 |
Values are mean±SD or the number of patients.
*Significant difference p<0.05 between with and without dysphagia.
M, men; MMSE, Mini-Mental State Examination; PD, Parkinson's disease; UPDRS, unified Parkinson's disease rating scale; W, women.
Figure 2The time needed for swallowing initiation and the 30 s swallowing frequency in Parkinson's disease (PD) patients with and without dysphagia at baseline and after a 3-year follow-up period. There were significant differences between PD patients with and without dysphagia in the time needed for swallowing initiation at baseline and after a 3-year follow-up period (p<0.05) (A). In the 30 s swallowing frequency, there was no significant difference between PD patients with and without dysphagia at baseline (p>0.05), but a significant difference between the two groups was evident after the 3-year follow-up period (p<0.05) (B).
Figure 3Cross-sectional analyses of brain maps showing the differences between Parkinson's disease (PD) patients with dysphagia and normal control subjects at baseline (A) and after a 3-year follow-up period (B). Various areas showed differences in the standardised PET data, and areas with a height threshold of p<0.001 (uncorrected) and an extent threshold of 40 voxels are illustrated. A comparison of regional cerebral glucose metabolism values demonstrated hypometabolism in the SMA and ACC in the PD patients with dysphagia compared with normal control subjects at baseline (uncorrected p<0.001, threshold=40 voxels) (A). After a 3-year follow-up period, the areas of hypometabolism included not only the SMA and the ACC but also the bilateral medial frontal lobes, middle cingulate cortex, thalamus and right superior, middle, inferior and orbital frontal gyri (uncorrected p<0.001, threshold=40 voxels) (B).
Figure 4Cross-sectional analyses of brain maps showing differences between PD patients without dysphagia and normal control subjects at baseline (A) and after a 3-year follow-up period (B). Various areas showed differences in the standardised PET data, and areas with a height threshold of p<0.001 (uncorrected) and an extent threshold of 40 voxels are illustrated. The PD patients without dysphagia showed virtually no hypometabolism at baseline (uncorrected p<0.001, threshold=40 voxels) (A) and only a small degree of hypometabolism in the SMA and ACC after a 3-year follow-up period (uncorrected p<0.001, threshold=40 voxels) (B) compared with normal control subjects.